BioSpace News Archive

Ceruvia Lifesciences, a leading neurotransformational biopharmaceutical company, today announced the first participant has been dosed in their Phase 1 clinical trial of NYPRG-101 (2-bromo- d -lysergic acid diethylamide) in healthy adult participants.

Adolore Biotherapeutics, Inc. (“Adolore” or the “Company”) today announced the appointments of Roelof Rongen, MSE, MBA as Chief Executive Officer and Director, and Mark C. Rogers, MD, MBA as a member of the Company’s Board of Directors.

Biological Dynamics, Inc., a company developing and commercializing its proprietary ExoVerita™ platform for early disease detection and other applications, today announced Peter C. Wulff as Chief Financial Officer effective January 1, 2023.

Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, today announced that the U.S. Patent and Trademark Office (USPTO) has granted a patent (Patent No. US 11,555,070) for its anti-claudin 18.2 antibodies.

Cycle Pharmaceuticals Ltd (Cycle) has today welcomed the news that multiple sclerosis (MS) patients in the US currently being treated with Gilenya, or generic fingolimod to have access to appropriate patient support services alongside the bioequivalent, TASCENSO ODT1 following the withdrawal of Gilenya patient support on March 31st 2023.

Beyond Air, Inc., a commercial stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension, and, through its affiliate Beyond Cancer, Ltd., ultra-high concentration nitric oxide for the treatment of solid tumors, announced that it will report financial results for its third fiscal quarter ended December 31, 2022 on Thursday, February 9, 2023.

GoodCap Pharmaceuticals Inc. (“GoodCap” or the “Company”), is pleased to announce the appointment of Dr. Laura Targownik, MD, to its Scientific Advisory Board.

CDx Diagnostics, Inc. announced the publication of a new study, Utility of WATS-3D as an Adjunct to Forceps Biopsies in Surveillance of Barrett’s Patients Post Endoscopic Eradication Therapy, in the American Society for Gastrointestinal Endoscopy journal iGIE by authors F. Scott Corbett MD, FASGE, Robert D. Odze MD, and Matthew J. McKinley MD.

Duke University’s BIG IDEAs Lab and Evidation, the company that connects directly with individuals to measure and improve health in everyday life, announced today that they have established a partnership with the goal of increasing diversity and representation in digital health studies.

Land Science®, a division of REGENESIS®, and the recognized leader in contaminant vapor intrusion mitigation technologies, was recently awarded a U.S. patent for the innovative use of a reinforced geomembrane comprised of an encapsulated, metalized layer and installed with Nitra-Core™, a spray-applied nitrile-modified asphalt.